HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robson Coutinho-Silva Selected Research

(N-(1-(((cyanoimino)(5-quinolinylamino) methyl) amino)- 2,2- dimethylpropyl)- 2- (3,4- dimethoxyphenyl)acetamide)

4/2022The P2X7 Receptor Promotes Colorectal Inflammation and Tumorigenesis by Modulating Gut Microbiota and the Inflammasome.
1/2014Prophylactic systemic P2X7 receptor blockade prevents experimental colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robson Coutinho-Silva Research Topics

Disease

29Inflammation (Inflammations)
07/2022 - 01/2008
28Infections
01/2022 - 09/2003
5Neoplasms (Cancer)
04/2022 - 01/2017
5Sepsis (Septicemia)
01/2021 - 01/2015
4Silicosis
01/2020 - 01/2014
4Colitis
11/2017 - 01/2014
3Hyperhomocysteinemia
07/2022 - 12/2015
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2022 - 03/2014
3Communicable Diseases (Infectious Diseases)
01/2022 - 01/2018
3Fibrosis (Cirrhosis)
01/2020 - 12/2009
3Cutaneous Leishmaniasis
01/2018 - 09/2011
3Schistosomiasis (Bilharziasis)
01/2016 - 03/2013
2Neuroinflammatory Diseases
07/2022 - 01/2016
2Cognitive Dysfunction
07/2022 - 01/2021
2Periodontal Diseases (Periodontal Disease)
12/2021 - 01/2019
2Body Weight (Weight, Body)
07/2021 - 01/2020
2Leishmaniasis
01/2021 - 01/2016
2Peritonitis
01/2021 - 01/2020
2Pneumonia (Pneumonitis)
01/2020 - 01/2014
2Lung Diseases (Lung Disease)
01/2020 - 09/2015
2Periodontitis
01/2020 - 01/2019
2Toxoplasmosis
01/2019 - 01/2017
2Necrosis
01/2015 - 12/2012
2Lung Injury
01/2015 - 12/2011
2Tuberculosis (Tuberculoses)
07/2014 - 08/2013
1Ulcer
04/2022
1Colitis-Associated Neoplasms
04/2022
1Carcinogenesis
04/2022
1Wounds and Injuries (Trauma)
01/2021
1Edema (Dropsy)
01/2020
1Ureteral Obstruction
01/2020
1Parasitic Diseases (Parasitic Disease)
01/2019
1Cerebral Toxoplasmosis
01/2019
1Asthma (Bronchial Asthma)
01/2019
1Brain Injuries (Brain Injury)
10/2017
1Delirium
10/2017

Drug/Important Bio-Agent (IBA)

34Purinergic P2X7 ReceptorsIBA
04/2022 - 12/2011
27Adenosine Triphosphate (ATP)IBA
01/2022 - 12/2003
16CytokinesIBA
12/2021 - 12/2009
10Purinergic Receptors (Receptors, Purine)IBA
01/2019 - 05/2005
9InflammasomesIBA
04/2022 - 09/2015
8NucleotidesIBA
01/2021 - 05/2005
4Proteins (Proteins, Gene)FDA Link
07/2021 - 02/2016
4CollagenIBA
01/2021 - 01/2014
4Adenosine (Adenocard)FDA LinkGeneric
01/2020 - 01/2017
3HomocysteineIBA
07/2022 - 12/2015
3Messenger RNA (mRNA)IBA
01/2020 - 05/2005
3Silicon Dioxide (Silica)FDA LinkGeneric
01/2020 - 01/2014
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 01/2018
3Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2018 - 01/2015
3Uridine Triphosphate (UTP)IBA
01/2018 - 09/2011
2(N-(1-(((cyanoimino)(5-quinolinylamino) methyl) amino)- 2,2- dimethylpropyl)- 2- (3,4- dimethoxyphenyl)acetamide)IBA
04/2022 - 01/2014
2Adenosine Diphosphate (ADP)IBA
01/2021 - 01/2016
2Purinergic P2Y1 ReceptorsIBA
01/2021 - 01/2016
2ChemokinesIBA
12/2020 - 01/2016
2coomassie Brilliant BlueIBA
01/2020 - 01/2014
2Virulence Factors (Pathogenicity Factors)IBA
01/2019 - 06/2009
2Sulfates (Sulfates, Inorganic)IBA
12/2018 - 11/2017
2Hydrogen Sulfide (Sulfide, Hydrogen)IBA
12/2018 - 11/2017
2OxazoloneIBA
11/2017 - 01/2017
2AcidsIBA
01/2017 - 01/2014
2EnzymesIBA
01/2017 - 07/2014
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016 - 01/2008
2LipopolysaccharidesIBA
12/2011 - 01/2008
1Ibuprofen (Motrin)FDA LinkGeneric
07/2022
1Synapsins (Synapsin I)IBA
07/2022
1Rivastigmine (Exelon)FDA LinkGeneric
07/2022
1AcetylcholinesteraseIBA
07/2021
1SuspensionsIBA
07/2021
1Caspase 3 (Caspase-3)IBA
07/2021
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
07/2021
1Interleukin-10 (Interleukin 10)IBA
07/2021
1NeurotoxinsIBA
01/2021
1Meglumine AntimoniateIBA
01/2021
1Clemastine (Clemastine Fumarate)FDA LinkGeneric
01/2021
1Dietary FiberFDA Link
01/2021
1Pharmaceutical PreparationsIBA
01/2021
1Minocycline (Cyclops)FDA LinkGeneric
01/2021
1pexidartinibIBA
01/2021
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021
1Macrophage Colony-Stimulating FactorIBA
01/2021
1Uric Acid (Urate)IBA
01/2020
1CD39 antigenIBA
01/2020
1Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2020
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2020
1NitritesIBA
01/2020
1NucleotidasesIBA
01/2020
1Purinergic P2Y Receptor AntagonistsIBA
01/2020
15'-Nucleotidase (5' Nucleotidase)IBA
01/2020
1GTP-Binding Proteins (G-Protein)IBA
01/2020
1Clopidogrel (Plavix)FDA Link
01/2020
1CreatineIBA
01/2019
1Leukotriene B4IBA
01/2019
1Interleukin-5 (Interleukin 5)IBA
01/2019
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2018
1Ligand-Gated Ion ChannelsIBA
01/2018
1HMGB1 Protein (HMG1)IBA
01/2018
1LeukotrienesIBA
01/2018

Therapy/Procedure

5Ligation
12/2020 - 09/2003
3Punctures
12/2020 - 01/2015